Department of Surgery, University of Washington, Harborview Medical Center, 325 9th Ave, Seattle, WA 98104, USA..
Shock. 2011 Nov;36(5):435-9. doi: 10.1097/SHK.0b013e318231ee2e.
Hypertonic saline (HS) has been investigated as an immune modulator following hemorrhagic shock and sepsis. The polymorphonuclear neutrophil (PMN) response to HS is regulated by the release of ATP, which is converted to adenosine and activates adenosine receptors. Binding to A3 adenosine receptors promotes PMN activation, and inhibition of A3 receptors improves the efficacy of HS resuscitation. A3 receptor expression of PMNs has not been previously evaluated in injured patients. Whole blood was obtained from 10 healthy volunteers and 60 injured patients within 2 h of injury. Inclusion criteria were blunt or penetrating injury with evidence of hypovolemic shock (systolic blood pressure [SBP] ≤90 mmHg and base deficit ≥6 mEq/L or need for blood transfusion) or evidence of severe traumatic brain injury including initial Glasgow Coma Scale score of 8 or less or evidence of traumatic brain injury on head computed tomography scan (head Abbreviated Injury Score ≥3) or intubation in the field or emergency department. A3 receptor expression was assessed by flow cytometry. Polymorphonuclear neutrophils were also exposed to fMLP or HS (20-40 mM) in vitro. Clinical data were collected including admission physiology, injury severity (Injury Severity Score [ISS]), development of multiple organ failure, and survival. In normal volunteers, less than 1% of PMNs expressed A3 receptors on the cell surface. A3 receptor expression was significantly higher in injured patients, and the level of expression correlated with the severity of injury (ISS ≥25: A3 positive PMN 36.6% vs. ISS <25: 16.2%; P = 0.019) and degree of hypovolemic shock (SBP ≤90 mmHg: A3 positive PMN 43.8% vs. SBP>90 mmHg: 20.6%; P = 0.008). Stimulation with fMLP or HS increased A3 expression in normal volunteers, but only in patients with ISS of less than 25 or without hypovolemic shock. A3 receptor expression on the surface of PMNs is upregulated by injury, and increased expression levels are associated with greater injury severity and hypovolemic shock. Hypertonic saline increases A3 expression of PMNs from healthy volunteers and less severely injured patients.
高渗盐水(HS)已被研究作为出血性休克和败血症后的免疫调节剂。多形核粒细胞(PMN)对 HS 的反应受 ATP 释放的调节,ATP 转化为腺苷并激活腺苷受体。与 A3 腺苷受体结合可促进 PMN 激活,抑制 A3 受体可提高 HS 复苏的疗效。PMN 的 A3 受体表达在受伤患者中尚未得到评估。将血液取自 10 名健康志愿者和 60 名受伤患者,这些患者在受伤后 2 小时内获得。纳入标准为钝性或穿透性损伤,伴有低血容量性休克的证据(收缩压[SBP]≤90mmHg 和碱缺失≥6mEq/L 或需要输血)或严重创伤性脑损伤的证据,包括初始格拉斯哥昏迷量表评分 8 分或更低,或头部计算机断层扫描(头部损伤严重程度评分≥3)上有创伤性脑损伤的证据,或在现场或急诊室插管。通过流式细胞术评估 A3 受体表达。体外还将 PMN 暴露于 fMLP 或 HS(20-40mM)。收集临床数据,包括入院生理、损伤严重程度(损伤严重程度评分[ISS])、多器官衰竭的发展和存活情况。在正常志愿者中,PMN 细胞表面表达的 A3 受体不到 1%。受伤患者中 A3 受体表达明显更高,表达水平与损伤严重程度相关(ISS≥25:A3 阳性PMN 36.6%比 ISS<25:16.2%;P=0.019)和低血容量休克程度(SBP≤90mmHg:A3 阳性PMN 43.8%比 SBP>90mmHg:20.6%;P=0.008)。fMLP 或 HS 刺激可增加正常志愿者中 A3 的表达,但仅在 ISS 小于 25 或无低血容量休克的患者中增加。PMN 表面的 A3 受体表达被损伤上调,并且表达水平的增加与更严重的损伤严重程度和低血容量休克相关。高渗盐水可增加来自健康志愿者和损伤程度较轻的患者的 PMN 的 A3 表达。